Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA

DA Nathanson, B Gini, J Mottahedeh, K Visnyei… - Science, 2014 - science.org
Intratumoral heterogeneity contributes to cancer drug resistance, but the underlying
mechanisms are not understood. Single-cell analyses of patient-derived models and clinical …

Neurosphere formation is an independent predictor of clinical outcome in malignant glioma

DR Laks, M Masterman-Smith, K Visnyei… - Stem …, 2009 - academic.oup.com
Renewable neurosphere formation in culture is a defining characteristic of certain brain
tumor initiating cells. This retrospective study was designed to assess the relationship among …

[HTML][HTML] Brain tumor stem cells as therapeutic targets in models of glioma

DR Laks, K Visnyei, HI Kornblum - Yonsei medical journal, 2010 - ncbi.nlm.nih.gov
At this time, brain tumor stem cells remain a controversial hypothesis while malignant brain
tumors continue to present a dire prognosis of severe morbidity and mortality. Yet, brain …

A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells

K Visnyei, H Onodera, R Damoiseaux, K Saigusa… - Molecular cancer …, 2011 - AACR
Glioblastoma (GBM) is among the most lethal of all cancers. GBM consist of a
heterogeneous population of tumor cells among which a tumor-initiating and treatment-resistant …

Hepatosplenic γδ T-cell lymphoma: an overview

K Visnyei, ML Grossbard, I Shapira - Clinical Lymphoma Myeloma and …, 2013 - Elsevier
Peripheral T-cell lymphomas are a heterogeneous group of lymphoid malignancies. Among
these, hepatosplenic γδ T-cell lymphoma (HTCL) represents an aggressive and treatment-…

Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway

I Nakano, K Joshi, K Visnyei, B Hu, M Watanabe… - Neuro …, 2011 - academic.oup.com
Glioblastoma multiforme (GBM) is a devastating disease, and the current therapies have only
palliative effect. Evidence is mounting to indicate that brain tumor stem cells (BTSCs) are a …

Cerebral hypoperfusion and delayed hippocampal response after induction of adult kaolin hydrocephalus

PM Klinge, A Samii, A Mühlendyck, K Visnyei… - Stroke, 2003 - Am Heart Assoc
Background and Purpose— In chronic hydrocephalus, a role for tissue hypoxia resulting
from cerebrovascular compression is suggested. The purpose of this study was to evaluate …

Roles of insulin and transferrin in neural progenitor survival and proliferation

…, AA Paucar, RL Jackson, K Visnyei… - Journal of …, 2008 - Wiley Online Library
Multipotent neural progenitor cells or neural stem cells (NSC) can be propagated in vitro
from a variety of sources and have great potential for neural repair. Although it is well known …

Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion

K Visnyei, KJ Tatsukawa, RI Erickson, S Simonian… - Experimental …, 2006 - Elsevier
Neural progenitor transplantation is a potential treatment for neurodegenerative diseases,
including Huntington's disease (HD). In the current study, we tested the potential of rat …

A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma

…, R Damoiseaux, B France, N Orozco, K Visnyei… - Neuro …, 2018 - academic.oup.com
Background Clinical trials of therapies directed against nodes of the signaling axis of
phosphatidylinositol-3 kinase/Akt/mammalian target of rapamycin (mTOR) in glioblastoma (GBM) …